Senior insider sale
EVP, CFO & CBO at DIANTHUS THERAPEUTICS, INC. /DE/ — senior position signals high conviction
$10.21M
122.59K shares
What this filing means
SAVITZ RYAN plans to sell 122.59K shares of DIANTHUS THERAPEUTICS, INC. /DE/ valued at approximately $10.21M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/9/2026ACC: 0001950047-26-003357
Officer· EVP, CFO & CBO
Since Feb 2026
122.59K
Shares to sell
$10.21M
Approx. market value
8.22K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
4/9/2026
8.22KTotal acquired8.22K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/9/2026 | Exercise of Stock Options Cash | 8.22K | — |
| Total | 8.22K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
114.37K
Market value
$9.49M
3/31/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
8.22K
Market value
$719.4K
4/9/2026
Total
Units
122.59K
Value
$10.21M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/31/2026 | 114.37K | $9.49M | — | Completed |
| Planned — Approximate Date | ||||
4/9/2026 | 8.22K | $719.4K | NASDAQ | Planned |
| Total | 122.59K | $10.21M | ||